A 35-year-old woman from Mumbai is admitted with acute meningitis. CSF analysis shows pleocytosis with predominant polymorphonuclear cells. A Gram stain of CSF is performed and shows Gram-negative diplococci with a kidney-bean appearance. The laboratory reports that the organism is oxidase-positive. However, the resident notices that the staining is somewhat uneven, with some organisms appearing more deeply stained than others. What is the most appropriate next step in confirming the identity and guiding immediate therapy?

Explanation

## Clinical Context The patient presents with acute bacterial meningitis with CSF findings consistent with **Neisseria meningitidis**: Gram-negative diplococci with kidney-bean morphology, oxidase-positive, and pleocytosis with PMN predominance. The uneven staining is a clue — meningococci possess a polysaccharide capsule that may not stain uniformly with Gram stain. ## Why Capsule Staining? **Key Point:** Neisseria meningitidis is an encapsulated organism. The polysaccharide capsule is poorly stained by Gram stain and may appear as a halo or unstained zone around the organism. Capsule stains (India ink, methylene blue, or Loeffler's methylene blue) specifically visualize this structure by negative staining, providing rapid confirmation of the organism's identity. **High-Yield:** In meningitis, capsule staining serves two purposes: 1. **Rapid identification** — confirms presence of a capsule, supporting Neisseria meningitidis diagnosis 2. **Clinical significance** — the capsule is the major virulence factor and is the target of meningococcal vaccines ## Diagnostic Pathway for Meningitis ```mermaid flowchart TD A[Acute meningitis with CSF pleocytosis]:::outcome --> B[Gram stain CSF]:::action B --> C{Gram-negative diplococci?}:::decision C -->|Yes| D{Kidney-bean shape + oxidase+?}:::decision D -->|Yes| E[Suspect N. meningitidis]:::outcome E --> F[Capsule stain: India ink/methylene blue]:::action F --> G{Capsule halo seen?}:::decision G -->|Yes| H[Presumptive meningococcal meningitis]:::outcome H --> I[Start ceftriaxone/cefotaxime immediately]:::action G -->|No| J[Consider other Gram-negative diplococci]:::action ``` **Clinical Pearl:** Meningococcal meningitis is a medical emergency. In India, empiric therapy with ceftriaxone (2 g IV 6-hourly) or cefotaxime should be started immediately upon clinical suspicion — do NOT wait for culture confirmation. Capsule staining provides rapid confirmation within 30 minutes. **Mnemonic:** **MENINGOCOCCAL CAPSULE = Polysaccharide** - **M**eningococcus = Neisseria meningitidis - **E**ncapsulated (polysaccharide) - **N**egative staining reveals capsule (India ink) - **I**dentification rapid (< 1 hour) - **N**ot stained by Gram (appears as halo) ## Why NOT the Other Options? | Option | Why Incorrect | |--------|---------------| | Gram stain on fresh/thinner smear | Gram staining does not visualize the capsule better with technique changes. The capsule is acellular and requires negative staining methods. | | Blood culture before antibiotics | While blood culture is important, it takes 24–48 hours to grow. Meningococcal meningitis has high mortality if antibiotics are delayed. Empiric therapy must start immediately based on CSF Gram stain findings. | | 16S rRNA sequencing | This is a molecular method used for confirmation in research or difficult cases, not for rapid bedside diagnosis. It takes hours to days and is not practical in acute meningitis. |